Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,844,203
  • Shares Outstanding, K 46,520
  • Annual Sales, $ 0 K
  • Annual Income, $ -270,120 K
  • 36-Month Beta 3.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.38

Price Performance

See More
Period Period Low Period High Performance
1-Month
145.28 +16.07%
on 06/25/18
170.84 -1.30%
on 07/13/18
+6.53 (+4.03%)
since 06/19/18
3-Month
137.38 +22.74%
on 04/25/18
177.14 -4.81%
on 05/15/18
-1.05 (-0.62%)
since 04/19/18
52-Week
59.57 +183.06%
on 10/25/17
195.97 -13.96%
on 01/31/18
+87.65 (+108.25%)
since 07/19/17

Most Recent Stories

More News
Sage Therapeutic Set to Possibly Pullback After Yesterday's Rally of 1.15%

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $160.42 to a high of $162.93. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

SAGE : 168.62 (+0.36%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that,...

SAGE : 168.62 (+0.36%)
Watch for Sage Therapeutic to Potentially Pullback After Gaining 2.48% Yesterday

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $151.02 to a high of $157.95. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high...

SAGE : 168.62 (+0.36%)
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sage Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of...

SAGE : 168.62 (+0.36%)
Sage Therapeutic Falls 4.27% on Heavy Volume: Watch For Potential Rebound

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $157.12 to a high of $165.50. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of...

SAGE : 168.62 (+0.36%)
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea

--Collaboration supports Shionogi's vision of creating a more vigorous society by exploring the potential to provide relief from the psychological uncertainty of depression with a novel treatment paradigm...

SAGE : 168.62 (+0.36%)
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea

--Collaboration supports Shionogi's vision of creating a more vigorous society by exploring the potential to provide relief from the psychological uncertainty of depression with a novel treatment paradigm...

SAGE : 168.62 (+0.36%)
Company News For Jun 13, 2018

Companies In The News are: TSLA,SAGE,RH,PLAY

PLAY : 49.51 (+0.88%)
TSLA : 320.23 (-1.12%)
RH : 138.62 (+3.77%)
SAGE : 168.62 (+0.36%)
Today's Research Reports on Stocks to Watch: Sage Therapeutics and Galmed Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 13, 2018 / It was an exciting day for biotech stocks Sage Therapeutics and Galmed Pharmaceuticals. Sage rose higher after announcing that the FDA has allowed expedited...

SAGE : 168.62 (+0.36%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Sage Therapeutic (SAGE , RDUS , ALNY , ICPT , ADRO )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

RDUS : 28.46 (+0.28%)
ALNY : 106.26 (+0.84%)
SAGE : 168.62 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SAGE with:

Business Summary

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product...

See More

Key Turning Points

2nd Resistance Point 172.07
1st Resistance Point 170.34
Last Price 168.62
1st Support Level 166.26
2nd Support Level 163.91

See More

52-Week High 195.97
Last Price 168.62
Fibonacci 61.8% 143.87
Fibonacci 50% 127.77
Fibonacci 38.2% 111.67
52-Week Low 59.57

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar